Alzheimer’s vaccine beginning human trials
A vaccine to stop Alzheimer's disease, spearheaded by an Australian immunologist, is beginning human trials next week.
The study between Professor Nikolai Petrovsky and a US-based Medical Institute has produced promising results in animal subjects.
Testing shows the death of nerve cells and progressive memory loss were delayed by producing antibodies to defend the brain against harmful proteins.
Phase one of the trial will be conducted in Adelaide and will take roughly a year to complete.
June 26, 2024
